179 related articles for article (PubMed ID: 15616032)
1. a-Series gangliosides mediate the effects of advanced glycation end products on pericyte and mesangial cell proliferation: a common mediator for retinal and renal microangiopathy?
Masson E; Troncy L; Ruggiero D; Wiernsperger N; Lagarde M; El Bawab S
Diabetes; 2005 Jan; 54(1):220-7. PubMed ID: 15616032
[TBL] [Abstract][Full Text] [Related]
2. Involvement of gangliosides in glucosamine-induced proliferation decrease of retinal pericytes.
Masson E; Wiernsperger N; Lagarde M; El Bawab S
Glycobiology; 2005 Jun; 15(6):585-91. PubMed ID: 15625180
[TBL] [Abstract][Full Text] [Related]
3. Growth modulation of retinal microvascular cells by early and advanced glycation products.
Ruggiero-Lopez D; Rellier N; Lecomte M; Lagarde M; Wiernsperger N
Diabetes Res Clin Pract; 1997 Jan; 34(3):135-42. PubMed ID: 9069564
[TBL] [Abstract][Full Text] [Related]
4. Glucosamine induces cell-cycle arrest and hypertrophy of mesangial cells: implication of gangliosides.
Masson E; Wiernsperger N; Lagarde M; El Bawab S
Biochem J; 2005 Jun; 388(Pt 2):537-44. PubMed ID: 15654767
[TBL] [Abstract][Full Text] [Related]
5. Ganglioside GM3 inhibits the high glucose- and TGF-beta1-induced proliferation of rat glomerular mesangial cells.
Kwak DH; Lee S; Kim SJ; Ahn SH; Song JH; Choo YK; Choi BK; Jung KY
Life Sci; 2005 Sep; 77(20):2540-51. PubMed ID: 15939439
[TBL] [Abstract][Full Text] [Related]
6. Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy.
Chibber R; Molinatti PA; Rosatto N; Lambourne B; Kohner EM
Diabetologia; 1997 Feb; 40(2):156-64. PubMed ID: 9049475
[TBL] [Abstract][Full Text] [Related]
7. Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys.
Lee EJ; Kang MK; Kim DY; Kim YH; Oh H; Kang YH
Nutrients; 2018 Jul; 10(7):. PubMed ID: 29987200
[TBL] [Abstract][Full Text] [Related]
8. Mechanism for the negative regulation of cell proliferation by ganglioside GM3 in high glucose-treated glomerular mesangial cells.
Rho YI; Kwak DH; Lee S; Ahn SH; Baek SH; Song JH; Choo YK; Choi BK; Jung KY
Life Sci; 2004 May; 75(1):51-62. PubMed ID: 15102521
[TBL] [Abstract][Full Text] [Related]
9. Glycosphingolipid changes induced by advanced glycation end-products.
Natalizio A; Ruggiero D; Lecomte M; Lagarde M; Wiernsperger N
Biochem Biophys Res Commun; 2001 Feb; 281(1):78-83. PubMed ID: 11178963
[TBL] [Abstract][Full Text] [Related]
10. The missing link - likely pathogenetic role of GM3 and other gangliosides in the development of diabetic nephropathy.
Vukovic I; Bozic J; Markotic A; Ljubicic S; Ticinovic Kurir T
Kidney Blood Press Res; 2015; 40(3):306-14. PubMed ID: 26043887
[TBL] [Abstract][Full Text] [Related]
11. Modification of enzymatic antioxidants in retinal microvascular cells by glucose or advanced glycation end products.
Paget C; Lecomte M; Ruggiero D; Wiernsperger N; Lagarde M
Free Radic Biol Med; 1998 Jul; 25(1):121-9. PubMed ID: 9655530
[TBL] [Abstract][Full Text] [Related]
12. The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression.
Pugliese G; Pricci F; Leto G; Amadio L; Iacobini C; Romeo G; Lenti L; Sale P; Gradini R; Liu FT; Di Mario U
Diabetes; 2000 Jul; 49(7):1249-57. PubMed ID: 10909985
[TBL] [Abstract][Full Text] [Related]
13. Sulforaphane inhibits advanced glycation end product-induced pericyte damage by reducing expression of receptor for advanced glycation end products.
Maeda S; Matsui T; Ojima A; Takeuchi M; Yamagishi S
Nutr Res; 2014 Sep; 34(9):807-13. PubMed ID: 25241332
[TBL] [Abstract][Full Text] [Related]
14. Lysozyme enhances renal excretion of advanced glycation endproducts in vivo and suppresses adverse age-mediated cellular effects in vitro: a potential AGE sequestration therapy for diabetic nephropathy?
Zheng F; Cai W; Mitsuhashi T; Vlassara H
Mol Med; 2001 Nov; 7(11):737-47. PubMed ID: 11788787
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism.
Pugliese G; Pricci F; Romeo G; Pugliese F; Mené P; Giannini S; Cresci B; Galli G; Rotella CM; Vlassara H; Di Mario U
Diabetes; 1997 Nov; 46(11):1881-7. PubMed ID: 9356040
[TBL] [Abstract][Full Text] [Related]
16. The role of pulsatile flow in controlling microvascular retinal endothelial and pericyte cell apoptosis and proliferation.
Walshe TE; Connell P; Cryan L; Ferguson G; O'Brien C; Cahill PA
Cardiovasc Res; 2011 Feb; 89(3):661-70. PubMed ID: 21030535
[TBL] [Abstract][Full Text] [Related]
17. Ganglioside as an endogenous growth suppressor for glomerular mesangial cells.
Tsuboi N; Utsunomiya Y; Kawamura T; Kawano T; Hosoya T; Ohno T; Yamada H
Kidney Int; 2001 Oct; 60(4):1378-85. PubMed ID: 11576351
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of bovine retinal microvascular pericyte proliferation in vitro by adenosine.
Jackson JA; Carlson EC
Am J Physiol; 1992 Aug; 263(2 Pt 2):H634-40. PubMed ID: 1510160
[TBL] [Abstract][Full Text] [Related]
19. Liraglutide attenuates the migration of retinal pericytes induced by advanced glycation end products.
Lin WJ; Ma XF; Hao M; Zhou HR; Yu XY; Shao N; Gao XY; Kuang HY
Peptides; 2018 Jul; 105():7-13. PubMed ID: 29746877
[TBL] [Abstract][Full Text] [Related]
20. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
Kern TS; Tang J; Mizutani M; Kowluru RA; Nagaraj RH; Romeo G; Podesta F; Lorenzi M
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
